Evelo Biosciences Inc logo

Evelo Biosciences Inc Share Price (NASDAQ: EVLO)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 22 Aug 2024

Check the interactive Evelo Biosciences Inc Stock chart to analyse performance

Evelo Biosciences Inc Key Stats

Check Evelo Biosciences Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.0E-4
Open
$5.0E-4
Market Capitalization
$1.9K
Today's Volume
$600.0
Revenue TTM
$0.0
EBITDA
$-69.7M
Earnings Per Share (EPS)
$-15.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-6232.76%

Global Institutional Holdings in Evelo Biosciences Inc

  • Name

    Holdings %

  • Flagship Ventures Management, Inc.

    41.79%

  • Alyeska Investment Group, L.P.

    1.40%

  • Acadian Asset Management LLC

    0.25%

  • XTX Topco Ltd

    0.05%

Analyst Recommendation on Evelo Biosciences Inc Stock

Rating
Trend

Hold

    0%Buy

    57%Hold

    42%Sell

Based on 7 Wall street analysts offering stock ratings for Evelo Biosciences Inc(by analysts ranked 0 to 5 stars)

About Evelo Biosciences Inc

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Organization
Evelo Biosciences Inc
Employees
66
CEO
Mr. Craig R. Jalbert CIRA
Industry
Health Technology

Important FAQs about investing in EVLO Stock from India :

What is Evelo Biosciences Inc share price today?

Evelo Biosciences Inc share price today is as on at the close of the market. Evelo Biosciences Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Evelo Biosciences Inc share?

Evelo Biosciences Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Evelo Biosciences Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Evelo Biosciences Inc Stock (EVLO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evelo Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evelo Biosciences Inc Shares .

What is the minimum amount required to buy Evelo Biosciences Inc Stock (EVLO) from India?

Indian investors can start investing in Evelo Biosciences Inc (EVLO) shares with as little as ₹87.823 or $1 (as of September 17, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.23 in Evelo Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025). Learn more about fractional shares .

What are the returns that Evelo Biosciences Inc has given to Indian investors in the last 5 years?

Evelo Biosciences Inc stock has given 0.0% share price returns and 19.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?